These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 36585968)

  • 1. Vitreous humor proteome: unraveling the molecular mechanisms underlying proliferative and neovascular vitreoretinal diseases.
    Dos Santos FM; Ciordia S; Mesquita J; de Sousa JPC; Paradela A; Tomaz CT; Passarinha LAP
    Cell Mol Life Sci; 2022 Dec; 80(1):22. PubMed ID: 36585968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periostin in vitreoretinal diseases.
    Yoshida S; Nakama T; Ishikawa K; Nakao S; Sonoda KH; Ishibashi T
    Cell Mol Life Sci; 2017 Dec; 74(23):4329-4337. PubMed ID: 28913545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin (IL)-6, interleukin (IL)-8 levels and cellular composition of the vitreous humor in proliferative diabetic retinopathy, proliferative vitreoretinopathy, and traumatic proliferative vitreoretinopathy.
    Canataroglu H; Varinli I; Ozcan AA; Canataroglu A; Doran F; Varinli S
    Ocul Immunol Inflamm; 2005; 13(5):375-81. PubMed ID: 16422002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics profiling of vitreous humor reveals complement and coagulation components, adhesion factors, and neurodegeneration markers as discriminatory biomarkers of vitreoretinal eye diseases.
    Santos FM; Ciordia S; Mesquita J; Cruz C; Sousa JPCE; Passarinha LA; Tomaz CT; Paradela A
    Front Immunol; 2023; 14():1107295. PubMed ID: 36875133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysyl oxidase activity in the ocular tissues and the role of LOX in proliferative diabetic retinopathy and rhegmatogenous retinal detachment.
    Coral K; Angayarkanni N; Madhavan J; Bharathselvi M; Ramakrishnan S; Nandi K; Rishi P; Kasinathan N; Krishnakumar S
    Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4746-52. PubMed ID: 18566459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of interleukin-6 in vitreous from patients with proliferative vitreoretinal diseases.
    Kojima S; Yamada T; Tamai M
    Jpn J Ophthalmol; 2001; 45(1):40-5. PubMed ID: 11163044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
    Elner SG; Elner VM; Jaffe GJ; Stuart A; Kunkel SL; Strieter RM
    Curr Eye Res; 1995 Nov; 14(11):1045-53. PubMed ID: 8585935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human vitreous in proliferative diabetic retinopathy: Characterization and translational implications.
    Nawaz IM; Rezzola S; Cancarini A; Russo A; Costagliola C; Semeraro F; Presta M
    Prog Retin Eye Res; 2019 Sep; 72():100756. PubMed ID: 30951889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-8, nitric oxide and glutathione status in proliferative vitreoretinopathy and proliferative diabetic retinopathy.
    Cicik E; Tekin H; Akar S; Ekmekçi OB; Donma O; Koldaş L; Ozkan S
    Ophthalmic Res; 2003; 35(5):251-5. PubMed ID: 12920337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
    Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J
    Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of glutamine concentration in the vitreous humor in patients with proliferative vitreoretinopathy.
    Ishikawa S; Nakazawa M; Ishikawa A; Ishiguro S; Tamai M
    Curr Eye Res; 1995 Mar; 14(3):191-7. PubMed ID: 7796602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of Mir-21 Levels in the Vitreous Humor Is Associated with Development of Proliferative Vitreoretinal Disease.
    Usui-Ouchi A; Ouchi Y; Kiyokawa M; Sakuma T; Ito R; Ebihara N
    PLoS One; 2016; 11(6):e0158043. PubMed ID: 27351379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble TNF receptors in vitreoretinal proliferative disease.
    Limb GA; Hollifield RD; Webster L; Charteris DG; Chignell AH
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1586-91. PubMed ID: 11381065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble cellular adhesion molecules in proliferative vitreoretinopathy and proliferative diabetic retinopathy.
    Barile GR; Chang SS; Park LS; Reppucci VS; Schiff WM; Schmidt AM
    Curr Eye Res; 1999 Sep; 19(3):219-27. PubMed ID: 10487959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of connective tissue growth factor with fibrosis in vitreoretinal disorders in the human eye.
    Kuiper EJ; de Smet MD; van Meurs JC; Tan HS; Tanck MW; Oliver N; van Nieuwenhoven FA; Goldschmeding R; Schlingemann RO
    Arch Ophthalmol; 2006 Oct; 124(10):1457-62. PubMed ID: 17030714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated Activating Transcription Factor 4 and Glucose-Regulated 78 Kda Protein Levels Correlate with Inflammatory Cytokines in the Aqueous Humor and Vitreous of Proliferative Diabetic Retinopathy.
    Wang Y; Gao S; Zhu Y; Shen X
    Curr Eye Res; 2017 Aug; 42(8):1202-1208. PubMed ID: 28497987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth factors/chemokines in diabetic vitreous and aqueous alter the function of bone marrow-derived progenitor (CD34⁺) cells in humans.
    Balaiya S; Grant MB; Priluck J; Chalam KV
    Am J Physiol Endocrinol Metab; 2014 Oct; 307(8):E695-702. PubMed ID: 25159325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitreous Humor Proteome: Targeting Oxidative Stress, Inflammation, and Neurodegeneration in Vitreoretinal Diseases.
    Santos FM; Mesquita J; Castro-de-Sousa JP; Ciordia S; Paradela A; Tomaz CT
    Antioxidants (Basel); 2022 Mar; 11(3):. PubMed ID: 35326156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of pentosidine in the vitreous of eyes with proliferative diabetic retinopathy, proliferative vitreoretinopathy and retinal detachment.
    Tomé CC; De Rojas Silva MV; Rodríguez-García J; Rodríguez-Segade S; Sánchez-Salorio M
    Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1272-6. PubMed ID: 15947940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gelatinase B in proliferative vitreoretinal disorders.
    Abu El-Asrar AM; Dralands L; Veckeneer M; Geboes K; Missotten L; Van Aelst I; Opdenakker G
    Am J Ophthalmol; 1998 Jun; 125(6):844-51. PubMed ID: 9645722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.